Financials

  • Market Capitalization 701.52 M
  • Employee 88
  • Founded 2016
  • CEO N/A
  • Website www.bridgebio.com
  • Headquarter Delaware, United States
  • FIGI BBG01L3GYF02
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-2.91
Relación precio/flujo de caja
34.38

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
2688
STTK
Shattuck Labs, Inc. - Common Stock
7.19 USD-6.01%-1.37%+4.96%+619.00%721.61 M USD
2689
CTMX
CytomX Therapeutics, Inc. - Common Stock
3.31 USD-3.22%-0.60%+2.48%+59.90%721.25 M USD
2704
ALLO
Allogene Therapeutics, Inc. - Common Stock
2.03 USD-2.87%-2.40%+16.67%+72.03%701.35 M USD
2705
TECX
Tectonic Therapeutic, Inc. - Common Stock
35.84 USD-2.34%-3.84%+20.15%+108.98%700.65 M USD